XPOF vs ARHS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

XPOF

30.0
AI Score
VS
ARHS Wins

ARHS

35.2
AI Score

Investment Advisor Scores

XPOF

30score
Recommendation
AVOID NEW MONEY

ARHS

35score
Recommendation
EXTENDED

AI Analyst Insights

Detailed Metrics Comparison

Metric XPOF ARHS Winner
Forward P/E 10 15.2207 XPOF
PEG Ratio 0 0 Tie
Revenue Growth -13.4% 7.4% ARHS
Earnings Growth -81.7% 12.4% ARHS
Tradestie Score 30.0/100 35.2/100 ARHS
Profit Margin -14.8% 4.9% ARHS
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY EXTENDED ARHS

Relative Price Performance (Last 90 Days)

XPOF 1M: +15.3% · 3M: -32.5% ARHS 1M: +27.7% · 3M: +45.6%

Current Technical Phase

XPOF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -12.5%), weak momentum, RSI 40

RSI (14): 39.8 · Price: $4.27

ARHS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.4% over 20 days), RSI 72

RSI (14): 72.3 · Price: $11.52

Fundamentals Snapshot

Metric XPOF ARHS
Market Cap — —
Forward P/E 6.5 20.0
Trailing P/E — 21.9
Revenue (TTM) — —
Revenue Growth -0.1% 0.1%
Gross Margin 0.7% 0.4%
Operating Margin 0.2% 0.1%
EPS -1.49 0.50
Dividend Yield — 0.00%

Frequently Asked Questions

Based on our detailed analysis, ARHS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.